* Gohealth Inc GOCO.OQ GOCO.O is expected to show a fall
in
quarterly revenue when it reports results on August 15.
* The Chicago Illinois-based company is expected to report
a
33.9% decrease in revenue to $130.212 million from $196.9
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Gohealth Inc is for
a
loss of 23 cents per share. For the same quarter last year, the
company reported a loss of 12 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 4
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Gohealth
Inc is
$1, above its last closing price of $0.90.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2022 -0.09 -0.09 -0.12 Missed -35.3
Dec. 31 2022 -0.14 0.15 2.01 Beat 1,255.
1
Sep. 30 2021 -0.09 -0.10 -0.18 Missed -80.9
Jun. 30 2021 -0.05 -0.04 -0.12 Missed -170.9
Mar. -0.01 -0.01 -0.02 Missed -106
31 2021
Dec. 31 2020 0.44 0.45 0.41 Missed -8.2
Sep. 30 2020 -0.02 -0.01 -0.65 Missed -4,297
.8
Jun. 30 2020 -0.04 -0.04 -0.06 Missed -50
This summary was machine generated August 13 at 00:49 GMT. All
figures in US dollars unless otherwise stated